China Pharma Inc. (CPHI)
0.30
0.04 (13.72%)
At close: Mar 27, 2025, 3:59 PM
0.29
-2.75%
Pre-market: Mar 28, 2025, 07:31 AM EDT
China Pharma Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 |
| Revenue | 7.01M | 8.1M | 9.64M | 10.87M | 10.92M | 12.33M | 13.21M | 15.57M | 20.35M | 22.13M | 32.81M | 54.51M | 81.17M | 74.39M | 61.7M | 50.97M | 33.19M | 21.84M | 8.66M | 23.27K | 110.08K | 37.49K |
| Cost of Revenue | 7.29M | 8.6M | 9.29M | 8.91M | 9.44M | 10.36M | 10.74M | 12.35M | 18.89M | 19.47M | 29.59M | 40.43M | 52.18M | 44.11M | 36.05M | 25.68M | 17.62M | 11.75M | 4.17M | 47.68K | n/a | n/a |
| Gross Profit | -281.08K | -493.92K | 349.27K | 1.95M | 1.48M | 1.97M | 2.47M | 3.22M | 1.46M | 2.67M | 3.22M | 14.08M | 28.99M | 30.28M | 25.65M | 25.29M | 15.57M | 10.1M | 4.49M | -24.41K | 110.08K | 37.49K |
| Operating Income | -2.75M | -3.55M | -3.12M | -2.46M | -3.39M | -3.97M | -4.5M | -4.19M | -14.2M | -36.55M | -14.91M | 6.5M | 22.03M | 24.66M | 22.61M | 19.73M | 12.25M | 8.62M | 4.24M | -117.37K | -155.64K | -714.83K |
| Interest Income | 6.6K | 10.76K | 3.04K | 5.67K | 27.53K | 38.52K | 64.41K | 130.57K | 119.92K | 69.74K | 8.46K | 4.94K | 7.21K | 15.41K | 30.7K | 45.17K | 31.8K | 991.00 | 769.00 | n/a | n/a | n/a |
| Pretax Income | -3.08M | -3.97M | -3.4M | -2.87M | -20.7M | -10.86M | -19.15M | -8.87M | -15.35M | -39.47M | -18.95M | 5.6M | 22.71M | 26.1M | 22.49M | 19.54M | 12.66M | 8.59M | 4.05M | -117.37K | -180.17K | -1.1M |
| Net Income | -3.08M | -10.22M | -3.94M | -3.16M | -21.02M | -10.75M | -19.28M | -9.18M | -15.41M | -26.05M | -20.01M | 4.62M | 19.27M | 23.41M | 20.23M | 17.83M | 12.82M | 8.59M | 3.8M | -504.29K | -226.37K | -1.1M |
| Selling & General & Admin | 2.25M | 2.87M | 3.15M | 4.04M | 4.64M | 5.77M | 6.87M | 7.39M | 16.34M | 36.42M | 16.44M | 7.28M | 7.16M | 5.58M | 4.85M | 5.56M | 3.32M | 1.47M | 247.03K | 92.96K | 265.72K | 752.32K |
| Research & Development | 240.08K | 185.86K | 318.96K | 377.96K | 229.64K | 172.38K | 90.47K | 365.97K | 961.9K | 2.8M | 1.68M | 438.66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | -15.76K | 93.85K | n/a | 115.19B | 7,576.5B | n/a | 4,833.8B | n/a | n/a | n/a | n/a | 1,464.7B | -193.59K | 505.22K | -1.82M | 1.85B | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 2.47M | 3.15M | 3.46M | 4.42M | 4.87M | -12.42M | -21.15M | -11.37M | -15.76M | -41.43M | -21.83M | -8.17M | 6.96M | 6.09M | 3.04M | 5.56M | 3.32M | 1.47M | 247.03K | 92.96K | 265.72K | 752.32K |
| Interest Expense | 333.6K | 434.62K | 542K | 294.16K | 321.72K | 451.26K | 539.33K | 849.56K | 1.17M | 785.8K | 348.7K | 308.38K | 255.2K | 168.26K | 154.18K | 131.03K | 237.4K | 145.88K | 186.45K | 5.59K | 5.59K | 49.85K |
| Selling & Marketing Expenses | 780.33K | 1.07M | 1.5M | 2.22M | 2.35M | 3.22M | 3.46M | 4.04M | 4.29M | 3.35M | 3.28M | 3.54M | 3.44M | 2.54M | 2.71M | 2.04B | n/a | n/a | n/a | n/a | 172.76K | n/a |
| Cost & Expenses | 9.76M | 5.54M | 12.76M | 13.33M | 14.31M | -2.07M | -10.4M | 978.03K | 3.12M | -21.96M | 7.76M | 32.26M | 59.14M | 50.19M | 39.08M | 31.24M | 20.94M | 13.22M | 4.41M | 140.64K | 265.72K | 752.32K |
| Income Tax | n/a | 6.25M | 542K | 294.16K | 321.72K | 109.99K | 122.63K | 308.18K | 60.44K | 77.04K | 1.06M | 983.92K | 3.44M | 2.69M | 2.26M | 1.71M | -162.87K | -217.96K | 252.1K | 762.66K | 95.25K | 678.89K |
| Shares Outstanding (Basic) | 3.38M | 5.26M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M |
| Shares Outstanding (Diluted) | 3.38M | 5.26M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M | 4.61M |
| EPS (Basic) | -0.91 | -1.94 | -0.85 | -0.72 | -4.82 | -2.47 | -4.42 | -2.11 | -3.54 | -5.99 | -4.6 | 1.06 | 4.40 | 5.40 | 4.30 | 4.40 | 3.50 | 2.50 | 3.40 | -0.45 | -0.35 | -1.95 |
| EPS (Diluted) | -0.91 | -1.94 | -0.85 | -0.72 | -4.82 | -2.47 | -4.42 | -2.11 | -3.54 | -5.98 | -4.59 | 1.06 | 4.40 | 5.40 | 4.30 | 4.40 | 3.40 | 2.50 | 3.40 | -0.45 | -0.35 | -1.95 |
| EBITDA | 8.44K | -837.69K | 230.34K | 106.85K | -17.45M | -7.15M | -15.32M | -4.95M | -10.58M | -36.9M | -16.99M | 7.37M | 24.14M | 27.77M | 24.02M | 20.39M | 12.67M | 9.02M | 4.49M | 768.15K | 386.82K | -383.44K |
| Depreciation & Amortization | 2.75M | 2.7M | 3.09M | 2.68M | 2.93M | 3.26M | 3.29M | 3.08M | -3.6M | -1.79M | -1.61M | -1.46M | 1.17M | 1.51M | 1.4M | 719.48K | 422.44K | 397K | 250.18K | 504.19K | 67.27K | 83.31K |